Drug Promotion: Growth In Digital Marketing Warrants New Oversight Approaches, Experts Say
Executive Summary
Panelists at a recent Duke-Margolis meeting cite growing use of native ads and patient influencers, as well as the limited attention given to presentation of risk information, in calling for a re-examination of how pharmaceutical promotion on digital platforms is regulated.
You may also be interested in...
Social Media: Use Of Influencers In Drug Promotion Requires Guardrails, Experts Say
Careful identification and vetting of spokespersons, training on FDA regulations, and development of content that conveys the typical patient experience are keys to successful and compliant influencer campaigns, advertising, legal and regulatory experts told a recent DIA conference.
Keeping Up With the Kardashians: US FDA Objects To Khloé’s Migraine Drug Promo
Agency cites video promoting Biohaven’s Nurtec ODT, which first aired on ABC’s TV show The View, for misleading comparative claims, inadequate display of risk information, and failure to submit promo for review.
OMG! Kim Kardashian Social Media Post For Morning Sickness Drug Draws FDA Warning
Instagram and Facebook post about Duchesnay’s Diclegis lacks risk information, agency notes.